Mycobacterium tuberculosis
"Mycobacterium tuberculosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.
Descriptor ID |
D009169
|
MeSH Number(s) |
B03.510.024.049.525.500.702 B03.510.460.400.410.552.552.702
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mycobacterium tuberculosis".
Below are MeSH descriptors whose meaning is more specific than "Mycobacterium tuberculosis".
This graph shows the total number of publications written about "Mycobacterium tuberculosis" by people in this website by year, and whether "Mycobacterium tuberculosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 2 | 0 | 2 |
1996 | 0 | 1 | 1 |
1998 | 3 | 0 | 3 |
2001 | 2 | 0 | 2 |
2002 | 0 | 1 | 1 |
2003 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2005 | 1 | 1 | 2 |
2006 | 4 | 2 | 6 |
2007 | 3 | 0 | 3 |
2008 | 4 | 2 | 6 |
2009 | 1 | 3 | 4 |
2010 | 4 | 1 | 5 |
2011 | 4 | 5 | 9 |
2012 | 4 | 2 | 6 |
2013 | 6 | 2 | 8 |
2014 | 9 | 1 | 10 |
2015 | 12 | 3 | 15 |
2016 | 6 | 3 | 9 |
2017 | 4 | 3 | 7 |
2018 | 4 | 1 | 5 |
2019 | 6 | 4 | 10 |
2020 | 13 | 2 | 15 |
2021 | 8 | 1 | 9 |
2022 | 7 | 1 | 8 |
2023 | 8 | 0 | 8 |
2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mycobacterium tuberculosis" by people in Profiles.
-
Phospholipase C epsilon-1 (PLC?1) mediates macrophage activation and protection against tuberculosis. Infect Immun. 2024 Apr 09; 92(4):e0049523.
-
Lung type 3 innate lymphoid cells respond early following Mycobacterium tuberculosis infection. mBio. 2024 Apr 10; 15(4):e0329923.
-
Saponin TQL1055 adjuvant-containing vaccine confers protection upon Mycobacterium tuberculosis challenge in mice. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2302070.
-
Mycobacterium tuberculosis infection drives differential responses in the bone marrow hematopoietic stem and progenitor cells. Infect Immun. 2023 10 17; 91(10):e0020123.
-
Mycobacterium tuberculosis carrying the rifampicin drug-resistance-conferring rpoB mutation H445Y is associated with suppressed immunity through type I interferons. mBio. 2023 Oct 31; 14(5):e0094623.
-
A protocol to analyze single-cell RNA-seq data from Mycobacterium tuberculosis-infected mice lung. STAR Protoc. 2023 Sep 15; 4(3):102544.
-
Rifampicin drug resistance and host immunity in tuberculosis: more than meets the eye. Trends Immunol. 2023 09; 44(9):712-723.
-
Poly(ADP-ribose) polymerase 9 mediates early protection against Mycobacterium tuberculosis infection by regulating type I IFN production. J Clin Invest. 2023 06 15; 133(12).
-
Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control. Nat Immunol. 2023 05; 24(5):855-868.
-
NK-like CD8+ ?d T cells are expanded in persistent Mycobacterium tuberculosis infection. Sci Immunol. 2023 03 31; 8(81):eade3525.